Connect with us

Health

Report warns of 'worryingly thin' antimicrobial treatments pipeline

SHARE:

Published

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Amsterdam-based NGO Access To Medicine Foundation (AMF) has published the fourth edition of its Antimicrobial Resistance Benchmark report. Chief Executive Officer, Jayasree K. Iyer, says that there are some positive signs with recent regulatory approvals for three antibiotics with innovative characteristics and seven promising products in late-stage development, but that overall the pipeline remains “worryingly thin” and far from picking up pace “industry investment has lost momentum”.

Smaller firms filling innovation gap
The report covers 25 companies, including large and - for the first time - small companies, and ten generic manufacturers. It focuses on three main areas: R&D, responsible manufacturing and appropriate access and stewardship.

The authors estimate that the number of projects from large research-based pharmaceutical companies has declined by 35% between...

Share this article:

Share this:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.

Trending